Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$34.94 3.8%
Market Cap
$2.4B
Price Target
Refer to Report
Volume
236.4K
52wk Range
$19.12 - $36.6
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.